Sterile protection against relapsing malaria with a single-shot vaccine

Vaccine development for Plasmodium vivax, an important human relapsing malaria, is lagging behind. In the case of the most deadly human malaria P. falciparum, unprecedented high levels of protection have been obtained by immunization with live sporozoites under accompanying chemoprophylaxis, which p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasini, Erica M., van der Wel, Annemarie Voorberg, Heijmans, Nicole, Klop, Onny, Zeeman, Anne-Marie, Oostermeijer, Herman, Nieuwenhuis, Ivonne, Garcia, Roberto Rodriguez, van der Werff, Nicole Onur, Hofman, Sam O., Verreck, Frank A. W., Remarque, Edmond J., Faber, Bart W., Kocken, Clemens H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612615/
https://www.ncbi.nlm.nih.gov/pubmed/36302860
http://dx.doi.org/10.1038/s41541-022-00555-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612615/
https://www.ncbi.nlm.nih.gov/pubmed/36302860
http://dx.doi.org/10.1038/s41541-022-00555-0

Ejemplares similares